Company Insider: Vice President of $XFLT Acquires 5,000 Shares

The recent insider purchase of 5,000 shares of $XFLT by Vice President John Yogi Spence has sparked interest in the market. The transaction, completed on February 19, 2026, amounted to approximately $19,500 and was disclosed through a recent SEC filing, as reported by Quiver Quantitative.

Following this purchase, Spence now holds 561,791 shares of $XFLT stock, representing a 0.9% increase in their holdings. This insider trade is part of a pattern of trading activity seen within the $XFLT company over the past 6 months, with a total of 3 transactions by insiders. Out of these 3 trades, 2 were purchases, while 1 was a sale.

An overview of the recent insider trading activities within $XFLT include Lauren Kristen Law purchasing 20,000 shares, Scott C Jones selling 13,008 shares, and Vice President John Yogi Spence acquiring 5,000 shares. To stay updated on insider transactions, individuals can refer to Quiver Quantitative’s insider trading dashboard.

In addition to insider transactions, there has been notable hedge fund activity in relation to $XFLT stock. Institutional investors have both added and decreased their positions in significant numbers over the last quarter. Notable changes among these investors include Sit Investment Associates Inc adding 2,893,917 shares, North Ground Capital adding 1,482,418 shares, and Pathstone Holdings, LLC, removing 1,186,027 shares from their portfolio.

Other key movements involve Morgan Stanley adding 912,735 shares, Rivernorth Capital Management, LLC adding 848,008 shares, Alpine Global Management, LLC adding 742,275 shares, and Matisse Capital adding 657,473 shares to their respective portfolios during the last quarter in 2025.

For more in-depth analysis of hedge funds’ stock portfolios, interested parties can refer to Quiver Quantitative’s institutional holdings dashboard. Please note that this article serves as information and is not intended as financial advice. Individuals are encouraged to refer to Quiver Quantitative’s disclaimers for further information.